BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35849558)

  • 1. Current Status of ABO-incompatible Liver Transplantation.
    Egawa H; Ohdan H; Saito K
    Transplantation; 2023 Feb; 107(2):313-325. PubMed ID: 35849558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation.
    Tajima T; Hata K; Haga H; Kusakabe J; Kageyama S; Yurugi K; Hishida R; Zhao X; Nishikori M; Nagao M; Takaori-Kondo A; Uemoto S; Hatano E
    Liver Transpl; 2023 Jul; 29(7):711-723. PubMed ID: 36749821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
    Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
    Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab administration one week before ABO-incompatible liver transplantation due to drug-induced acute liver failure with hepatic coma: a case report.
    Sasaki K; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Takahashi H; Doki Y; Eguchi H
    Clin J Gastroenterol; 2023 Oct; 16(5):709-714. PubMed ID: 37470968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.
    Egawa H; Teramukai S; Haga H; Tanabe M; Mori A; Ikegami T; Kawagishi N; Ohdan H; Kasahara M; Umeshita K
    Am J Transplant; 2014 Jan; 14(1):102-14. PubMed ID: 24279828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
    Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
    Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
    Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
    Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation.
    Oh J; Kim JM
    Clin Mol Hepatol; 2020 Jan; 26(1):1-6. PubMed ID: 30909688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
    Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
    Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
    Kim JD; Choi DL; Kim SG; Lee AJ
    Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenge to ABO blood type barrier in living donor liver transplantation.
    Egawa H
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):342-348. PubMed ID: 32665181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-Incompatible Living Donor Liver Transplantation With a Simplified Desensitization and Immunosuppression Protocol: A Single-Center Retrospective Study.
    Lee TB; Ko HJ; Shim JR; Choi BH; Ryu JH; Yang K
    Exp Clin Transplant; 2021 Jul; 19(7):676-685. PubMed ID: 34325624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation.
    Yamamoto H; Uchida K; Kawabata S; Isono K; Miura K; Hayashida S; Oya Y; Sugawara Y; Inomata Y
    Transplantation; 2018 Jan; 102(1):97-104. PubMed ID: 28938311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.